ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,972Medicare Part D Prescriptions Filled, Including Refills

Rank: 75 out of 324

$673K Total Retail Price of All Prescriptions

Rank: 51 out of 324

372 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
41% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 372 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

16% of this provider’s 372 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 7,995 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$61 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

29 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
SIMVASTATIN 430 351 1 1
HYDROCODONE-ACETAMINOPHEN 367 176 S3 2 5
LISINOPRIL 345 307 3 3
AMLODIPINE BESYLATE 291 248 4 4
LEVOTHYROXINE SODIUM 284 249 5 2
ATORVASTATIN CALCIUM 275 233 6 12
OMEPRAZOLE 243 190 7 6
CITALOPRAM HBR 221 193 8 16
FUROSEMIDE 206 181 9 7
METFORMIN HCL 195 179 10 9
METOPROLOL TARTRATE 169 137 11 14
GABAPENTIN 166 123 12 13
WARFARIN SODIUM 163 122 13 10
HYDROCHLOROTHIAZIDE 159 154 14 11
ZOLPIDEM TARTRATE 154 91 15 20
OXYCODONE HCL 150 44 S2 16 71
METOPROLOL SUCCINATE 127 114 17 17
TAMSULOSIN HCL 125 99 18 26
LOSARTAN POTASSIUM 116 116 19 15
NEXIUM 116 79 19 33
DONEPEZIL HCL 112 112 21 25
TRAMADOL HCL 104 57 22 19
CARVEDILOL 95 81 23 22
CRESTOR 94 63 24 28
OXYCODONE-ACETAMINOPHEN 93 54 S2 25 97
ADVAIR DISKUS 91 57 26 61
PREDNISONE 90 67 27 36
DICLOFENAC SODIUM 86 67 28 114
OXYCONTIN 85 56 S2 29 108
MORPHINE SULFATE ER 84 0 S2 30 89
LANTUS SOLOSTAR 84 54 30 85
AMITRIPTYLINE HCL 81 47 R 32 66
GLYBURIDE 80 62 R 33 59
ALENDRONATE SODIUM 80 66 33 24
PROAIR HFA 79 39 35 50
QUETIAPINE FUMARATE 76 66 36 69
MELOXICAM 74 72 37 29
ZETIA 72 46 38 68
FAMOTIDINE 64 48 39 62
GLIMEPIRIDE 64 59 39 37
LIPITOR 64 53 39 109
ESTRADIOL 63 51 R 42 98
FLUTICASONE PROPIONATE 63 50 42 32
PANTOPRAZOLE SODIUM 61 50 44 34
SERTRALINE HCL 60 60 45 23
PEN NEEDLE 59 23 46 146
CYMBALTA 58 45 47 45
POTASSIUM CHLORIDE 58 47 47 8
DILTIAZEM 24HR ER 57 57 49 149
NAMENDA 55 51 50 31
DIOVAN 55 55 50 56
HYDROMORPHONE HCL 55 0 S2 50 193
HYDROXYZINE HCL 53 22 R 53 237
LYRICA 52 0 54 107
CARBIDOPA-LEVODOPA 51 51 55 80
ATENOLOL 50 47 56 18
ACTOS 50 45 56 131
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 20, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.